CHI Advisors »

Graphite Bio shares owned by CHI Advisors

Quarter-by-quarter ownership of Graphite Bio shares owned by CHI Advisors from 13F filings

Historical chart of CHI Advisors investment in Graphite Bio

Tip: Access up to 7 years of quarterly data

All positions including Graphite Bio held by CHI Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Graphite Bio by CHI Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $573k 231k 2.48
2023-06-30 $600k 231k 2.60

More positions owned by CHI Advisors

Pliant Therapeutics (PLRX)
Repare Therapeutics Ord (RPTX)
Cullinan Oncology (CGEM)
Acelyrin (SLRN)
Orchard Therapeutics Spon Ads New
Larimar Therapeutics (LRMR)
Keros Therapeutics (KROS)
Ikena Oncology (IKNA)
Ultragenyx Pharmaceutical (RARE)
Compass Therapeutics (CMPX)
Mineralys Therapeutics (MLYS)
Inozyme Pharma (INZY)
Syros Pharmaceuticals Com New (SYRS)
Blueprint Medicines (BPMC)
Direxion Shs Etf Tr Daily S&p Biotec (LABD)

View all positions for CHI Advisors

Top funds holding Graphite Bio

Hsbc Holdings
American International
Lazard Asset Management

View all funds holding Graphite Bio